Sign in with Facebook
Or use your Businessweek account
Or use your Businessweek account
Already a Bloomberg.com user?
Sign in with the same account.
Rob Waters
Articles by Rob Waters
Recent
-
Gene Therapy Takes a Turn for the Better
Recent successes are giving drugmakers and patients hope -
Amgen: Strengthening Bones, Weakening Cancer?
Regulators may soon approve an Amgen drug, denosumab, for osteoporosis, but the payoff could be in oncology
Read
-
Amgen: Strengthening Bones, Weakening Cancer?
Regulators may soon approve an Amgen drug, denosumab, for osteoporosis, but the payoff could be in oncology
Discussed
Feed
Most Popular
- Here We Go Again: Retailers vs. Credit-Card Companies in Another Lawsuit
- Is This Google X's Plan to Wire the World?
- ‘Life-Size’ X-Wing Starfighter, World’s Biggest Lego Model, Lands in New York
- Inside Google's Secret Lab
- Why Can't McDonald's Offer Egg McMuffins All Day?
- Sweden's Suburbs, Sweden's Riots
- The Deficit Is Shrinking! (and Nobody Cares)
- In the Future We’ll All Be TaskRabbits
- Is This Google X's Plan to Wire the World?
- ‘Life-Size’ X-Wing Starfighter, World’s Biggest Lego Model, Lands in New York
- Inside Google's Secret Lab
- The Deficit Is Shrinking! (and Nobody Cares)
- Big Brands Are Missing the 'Social' in Social Media
- How the U.S. Government Hacks the World
- Here We Go Again: Retailers vs. Credit-Card Companies in Another Lawsuit
- Tesla Pays Off Its $465 Million 'Loser' Loan
- Philippines and Taiwan Fight—and Migrant Workers Suffer
- America’s Gift to Rival Economies? The Absurd H-1B Visa Cap
- Is This Google X's Plan to Wire the World?
- If Yahoo Buys Tumblr, What Will It Do With All That Porn?
- What's for Dinner, Big Mac or Egg McMuffin?
- 'Fast and Furious' Scandal Returns to Haunt Obama
- Google Is Winning the Innovation War against Apple
Market Summary
| Nikkei | 14612.45 | 128.47 |
| Topix | 1194.08 | 5.74 |
| Hang Seng | 22618.67 | -51.01 |
Links
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC Ad Choices